Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 5.42942730 |
2 | hemidesmosome assembly (GO:0031581) | 5.31629118 |
3 | translational termination (GO:0006415) | 5.19126361 |
4 | cell adhesion mediated by integrin (GO:0033627) | 4.99511254 |
5 | chondrocyte proliferation (GO:0035988) | 4.82812947 |
6 | ribosomal small subunit biogenesis (GO:0042274) | 4.81878588 |
7 | COPI coating of Golgi vesicle (GO:0048205) | 4.80063618 |
8 | Golgi transport vesicle coating (GO:0048200) | 4.80063618 |
9 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.66576796 |
10 | eosinophil chemotaxis (GO:0048245) | 4.60652613 |
11 | skin morphogenesis (GO:0043589) | 4.51865078 |
12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.47747507 |
13 | protein targeting to ER (GO:0045047) | 4.41682079 |
14 | translational elongation (GO:0006414) | 4.41068749 |
15 | regulation of metalloenzyme activity (GO:0048552) | 4.35468968 |
16 | cotranslational protein targeting to membrane (GO:0006613) | 4.34642802 |
17 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.30987188 |
18 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.23178877 |
19 | cellular protein complex disassembly (GO:0043624) | 4.18920946 |
20 | viral life cycle (GO:0019058) | 4.11339908 |
21 | outer ear morphogenesis (GO:0042473) | 4.11337389 |
22 | eosinophil migration (GO:0072677) | 4.10937099 |
23 | protein localization to endoplasmic reticulum (GO:0070972) | 4.09061787 |
24 | positive regulation of osteoblast proliferation (GO:0033690) | 4.02036781 |
25 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.99228570 |
26 | protein localization to endosome (GO:0036010) | 3.91944175 |
27 | hypotonic response (GO:0006971) | 3.91017122 |
28 | membrane raft organization (GO:0031579) | 3.86532435 |
29 | regulation of mononuclear cell migration (GO:0071675) | 3.85494336 |
30 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.82667748 |
31 | endodermal cell differentiation (GO:0035987) | 3.82216201 |
32 | ribosomal small subunit assembly (GO:0000028) | 3.82070325 |
33 | mesodermal cell differentiation (GO:0048333) | 3.81033416 |
34 | protein maturation by protein folding (GO:0022417) | 3.77721228 |
35 | desmosome organization (GO:0002934) | 3.77339536 |
36 | extracellular fibril organization (GO:0043206) | 3.76660928 |
37 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.73162229 |
38 | fibril organization (GO:0097435) | 3.70431576 |
39 | collagen fibril organization (GO:0030199) | 3.63036128 |
40 | middle ear morphogenesis (GO:0042474) | 3.56982500 |
41 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.55825686 |
42 | regulation of tight junction assembly (GO:2000810) | 3.55732671 |
43 | translational initiation (GO:0006413) | 3.55277228 |
44 | metanephric mesenchyme development (GO:0072075) | 3.54685440 |
45 | type B pancreatic cell proliferation (GO:0044342) | 3.53802606 |
46 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.53232128 |
47 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.46947304 |
48 | protein targeting to membrane (GO:0006612) | 3.45792313 |
49 | plasma membrane repair (GO:0001778) | 3.45039994 |
50 | wound healing, spreading of epidermal cells (GO:0035313) | 3.44211184 |
51 | membrane budding (GO:0006900) | 3.42602950 |
52 | protein complex disassembly (GO:0043241) | 3.40893449 |
53 | wound healing, spreading of cells (GO:0044319) | 3.31127822 |
54 | kidney mesenchyme development (GO:0072074) | 3.30847150 |
55 | cell-substrate junction assembly (GO:0007044) | 3.25636002 |
56 | cellular response to interferon-alpha (GO:0035457) | 3.25549720 |
57 | pattern specification involved in kidney development (GO:0061004) | 3.20427510 |
58 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.18760762 |
59 | protein retention in ER lumen (GO:0006621) | 3.16017854 |
60 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.13102641 |
61 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.12480341 |
62 | muscle cell migration (GO:0014812) | 3.11775282 |
63 | macromolecular complex disassembly (GO:0032984) | 3.11357690 |
64 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.09883509 |
65 | protein localization to cell surface (GO:0034394) | 3.08702019 |
66 | pinocytosis (GO:0006907) | 3.07453076 |
67 | macrophage chemotaxis (GO:0048246) | 3.05935830 |
68 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.05713576 |
69 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.05491242 |
70 | mesenchymal cell proliferation (GO:0010463) | 3.05147857 |
71 | positive regulation of actin filament depolymerization (GO:0030836) | 3.05013390 |
72 | vesicle fusion (GO:0006906) | 3.02993559 |
73 | peptidyl-proline hydroxylation (GO:0019511) | 3.01071031 |
74 | lens fiber cell development (GO:0070307) | 2.96482740 |
75 | positive regulation of pseudopodium assembly (GO:0031274) | 2.94168579 |
76 | protein heterotrimerization (GO:0070208) | 2.92652357 |
77 | cellular copper ion homeostasis (GO:0006878) | 2.89760290 |
78 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.89751198 |
79 | myeloid cell homeostasis (GO:0002262) | 2.88783292 |
80 | endothelial cell morphogenesis (GO:0001886) | 2.88426325 |
81 | regulation of interleukin-8 secretion (GO:2000482) | 2.88013202 |
82 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.83488085 |
83 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.83359222 |
84 | regulation of extracellular matrix disassembly (GO:0010715) | 2.83011799 |
85 | hippo signaling (GO:0035329) | 2.82457246 |
86 | positive regulation of macrophage activation (GO:0043032) | 2.81480586 |
87 | regulation of early endosome to late endosome transport (GO:2000641) | 2.80627442 |
88 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.79863493 |
89 | apoptotic cell clearance (GO:0043277) | 2.78863433 |
90 | cellular response to vitamin D (GO:0071305) | 2.77637654 |
91 | cellular response to vitamin (GO:0071295) | 2.76262382 |
92 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.76222883 |
93 | hepatocyte apoptotic process (GO:0097284) | 2.75561988 |
94 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.74053084 |
95 | atrioventricular valve morphogenesis (GO:0003181) | 2.73335796 |
96 | protein targeting to plasma membrane (GO:0072661) | 2.70582371 |
97 | actin filament depolymerization (GO:0030042) | 2.69806743 |
98 | epithelial cell-cell adhesion (GO:0090136) | 2.69204059 |
99 | ribosomal large subunit biogenesis (GO:0042273) | 2.67683541 |
100 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.67604285 |
101 | regulation of monocyte chemotaxis (GO:0090025) | 2.66108425 |
102 | regulation of chemokine secretion (GO:0090196) | 2.64823069 |
103 | negative regulation of fatty acid transport (GO:2000192) | 2.64776624 |
104 | ncRNA 3-end processing (GO:0043628) | 2.63256624 |
105 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.61405102 |
106 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.60849583 |
107 | virion attachment to host cell (GO:0019062) | 2.60405435 |
108 | adhesion of symbiont to host cell (GO:0044650) | 2.60405435 |
109 | substrate-dependent cell migration (GO:0006929) | 2.60397077 |
110 | mesenchyme morphogenesis (GO:0072132) | 2.60240358 |
111 | mitotic nuclear envelope reassembly (GO:0007084) | 2.59076196 |
112 | nuclear envelope reassembly (GO:0031468) | 2.59076196 |
113 | regulation of pseudopodium assembly (GO:0031272) | 2.58252170 |
114 | cellular response to zinc ion (GO:0071294) | 2.58244109 |
115 | regulation of histone phosphorylation (GO:0033127) | 2.57789136 |
116 | response to progesterone (GO:0032570) | 2.57235306 |
117 | keratinocyte proliferation (GO:0043616) | 2.56875093 |
118 | extracellular matrix disassembly (GO:0022617) | 2.56335863 |
119 | collagen metabolic process (GO:0032963) | 2.56243614 |
120 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.55574672 |
121 | platelet aggregation (GO:0070527) | 2.53703157 |
122 | positive chemotaxis (GO:0050918) | 2.53078850 |
123 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.52652000 |
124 | stress fiber assembly (GO:0043149) | 2.51026493 |
125 | positive regulation of vesicle fusion (GO:0031340) | 2.50300218 |
126 | positive regulation of chemokine secretion (GO:0090197) | 2.50184453 |
127 | epithelial to mesenchymal transition (GO:0001837) | 2.50002730 |
128 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.49378133 |
129 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.48524468 |
130 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.48431790 |
131 | GDP-mannose metabolic process (GO:0019673) | 2.47891999 |
132 | intermediate filament organization (GO:0045109) | 2.47355872 |
133 | branch elongation of an epithelium (GO:0060602) | 2.47353051 |
134 | virion assembly (GO:0019068) | 2.45629756 |
135 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.45236697 |
136 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.45176480 |
137 | wound healing (GO:0042060) | 2.45165387 |
138 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.45119304 |
139 | axon extension involved in axon guidance (GO:0048846) | 2.45119304 |
140 | pyrimidine nucleoside salvage (GO:0043097) | 2.44555747 |
141 | pyrimidine-containing compound salvage (GO:0008655) | 2.44555747 |
142 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.44381369 |
143 | negative regulation of anoikis (GO:2000811) | 2.44306235 |
144 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43592042 |
145 | regulation of heart morphogenesis (GO:2000826) | 2.43368455 |
146 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.41820711 |
147 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41503184 |
148 | barbed-end actin filament capping (GO:0051016) | 2.40823197 |
149 | establishment of protein localization to membrane (GO:0090150) | 2.40709594 |
150 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.37295187 |
151 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.37179506 |
152 | negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059) | 2.36815035 |
153 | fibrinolysis (GO:0042730) | 2.36393016 |
154 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.36085936 |
155 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.35006159 |
156 | morphogenesis of an endothelium (GO:0003159) | 2.34769356 |
157 | endothelial tube morphogenesis (GO:0061154) | 2.34769356 |
158 | autophagic vacuole fusion (GO:0000046) | 2.34444578 |
159 | regulation of anoikis (GO:2000209) | 2.34411965 |
160 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.34337925 |
161 | extracellular regulation of signal transduction (GO:1900115) | 2.34036567 |
162 | extracellular negative regulation of signal transduction (GO:1900116) | 2.34036567 |
163 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.32962640 |
164 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.32530637 |
165 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.31013657 |
166 | cyclooxygenase pathway (GO:0019371) | 2.30037587 |
167 | glomerular epithelial cell development (GO:0072310) | 2.29149981 |
168 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.28356326 |
169 | regulation of collagen metabolic process (GO:0010712) | 2.27389036 |
170 | protein hydroxylation (GO:0018126) | 2.27367963 |
171 | regulation of necrotic cell death (GO:0010939) | 2.26001223 |
172 | endothelial cell chemotaxis (GO:0035767) | 2.25423006 |
173 | hyaluronan catabolic process (GO:0030214) | 2.22177681 |
174 | localization within membrane (GO:0051668) | 2.20842758 |
175 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.20254454 |
176 | adhesion of symbiont to host (GO:0044406) | 2.19063424 |
177 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.16880886 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.90253523 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.39937238 |
3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.35726948 |
4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.85021291 |
5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 4.00215545 |
6 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.19290007 |
7 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.70017710 |
8 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.64048540 |
9 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.64048540 |
10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.55835923 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.54841530 |
12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48479096 |
13 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.27977602 |
14 | CJUN_26792858_Chip-Seq_BT549_Human | 2.27686961 |
15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25728575 |
16 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.18551415 |
17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.13440952 |
18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.09363993 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05059575 |
20 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.03637297 |
21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.00929606 |
22 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.97275469 |
23 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.91277832 |
24 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.85507585 |
25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.85402377 |
26 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.84930391 |
27 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.79850788 |
28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.78146214 |
29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.78146214 |
30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77940776 |
31 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.74864398 |
32 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.74628461 |
33 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71771547 |
34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.69444028 |
35 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.66015163 |
36 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.61720926 |
37 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.61462941 |
38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60111584 |
39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59294013 |
40 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.59289297 |
41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57853382 |
42 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57477524 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57041889 |
44 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55887092 |
45 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.53459193 |
46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52039707 |
47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51781211 |
48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48463243 |
49 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47929577 |
50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.44359275 |
51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38485027 |
52 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.37218115 |
53 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35691566 |
54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35565329 |
55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34264655 |
56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33636471 |
57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33175018 |
58 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31893105 |
59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31133490 |
60 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29885186 |
61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29633954 |
62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28665947 |
63 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27578735 |
64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.26033051 |
65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25527083 |
66 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.25013716 |
67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24907070 |
68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23126122 |
69 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21779074 |
70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20609156 |
71 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19890300 |
72 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19829178 |
73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18903515 |
74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16409756 |
75 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14019248 |
76 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.13958818 |
77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13898808 |
78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11562142 |
79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11287069 |
80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10779191 |
81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09679593 |
82 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09584004 |
83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08592560 |
84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07273948 |
85 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06466292 |
86 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06047470 |
87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05945183 |
88 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05707560 |
89 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.05279173 |
90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04561193 |
91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04490698 |
92 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04447922 |
93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03944101 |
94 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03408120 |
95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01379431 |
96 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99851007 |
97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99045847 |
98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98755194 |
99 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.98067319 |
100 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97225469 |
101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96918070 |
102 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96894481 |
103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96590713 |
104 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96141365 |
105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96057137 |
106 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.95911760 |
107 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94888073 |
108 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.93586012 |
109 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.93398681 |
110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93352016 |
111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93028927 |
112 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92614496 |
113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91739702 |
114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.91599302 |
115 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91579023 |
116 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91270420 |
117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90609810 |
118 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90409730 |
119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90381004 |
120 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89118273 |
121 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88596430 |
122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88204930 |
123 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88006373 |
124 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87776805 |
125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.87572356 |
126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86351630 |
127 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.85334574 |
128 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.84332141 |
129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83979499 |
130 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.82571936 |
131 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82254863 |
132 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80664630 |
133 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79452677 |
134 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.77657663 |
135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76965907 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 4.97262066 |
2 | MP0003705_abnormal_hypodermis_morpholog | 4.24862186 |
3 | MP0005275_abnormal_skin_tensile | 4.16952776 |
4 | MP0003191_abnormal_cellular_cholesterol | 3.31389608 |
5 | MP0005623_abnormal_meninges_morphology | 3.02249585 |
6 | MP0010352_gastrointestinal_tract_polyps | 2.68166996 |
7 | MP0002877_abnormal_melanocyte_morpholog | 2.65913921 |
8 | MP0010234_abnormal_vibrissa_follicle | 2.64466135 |
9 | MP0006082_CNS_inflammation | 2.63356962 |
10 | MP0003279_aneurysm | 2.62237812 |
11 | MP0005503_abnormal_tendon_morphology | 2.55387493 |
12 | MP0003566_abnormal_cell_adhesion | 2.51761912 |
13 | MP0001958_emphysema | 2.42840409 |
14 | MP0009384_cardiac_valve_regurgitation | 2.39993478 |
15 | MP0005023_abnormal_wound_healing | 2.39596135 |
16 | MP0004272_abnormal_basement_membrane | 2.26539354 |
17 | MP0003091_abnormal_cell_migration | 2.25852172 |
18 | MP0009840_abnormal_foam_cell | 2.21090307 |
19 | MP0002060_abnormal_skin_morphology | 2.19921315 |
20 | MP0005058_abnormal_lysosome_morphology | 2.16514453 |
21 | MP0010030_abnormal_orbit_morphology | 2.06941317 |
22 | MP0009379_abnormal_foot_pigmentation | 1.96813545 |
23 | MP0006054_spinal_hemorrhage | 1.95570799 |
24 | MP0004510_myositis | 1.91317239 |
25 | MP0003806_abnormal_nucleotide_metabolis | 1.87853207 |
26 | MP0005076_abnormal_cell_differentiation | 1.84829704 |
27 | MP0005165_increased_susceptibility_to | 1.84796697 |
28 | MP0000733_abnormal_muscle_development | 1.72017212 |
29 | MP0003453_abnormal_keratinocyte_physiol | 1.71063897 |
30 | MP0000858_altered_metastatic_potential | 1.69895353 |
31 | MP0000750_abnormal_muscle_regeneration | 1.69417062 |
32 | MP0003075_altered_response_to | 1.65588309 |
33 | MP0002282_abnormal_trachea_morphology | 1.64478426 |
34 | MP0009250_abnormal_appendicular_skeleto | 1.62002452 |
35 | MP0005508_abnormal_skeleton_morphology | 1.60462393 |
36 | MP0005257_abnormal_intraocular_pressure | 1.58751210 |
37 | MP0002796_impaired_skin_barrier | 1.56756975 |
38 | MP0005166_decreased_susceptibility_to | 1.56629384 |
39 | MP0001243_abnormal_dermal_layer | 1.55666196 |
40 | MP0000762_abnormal_tongue_morphology | 1.54685134 |
41 | MP0003828_pulmonary_edema | 1.49416403 |
42 | MP0003941_abnormal_skin_development | 1.46946982 |
43 | MP0001542_abnormal_bone_strength | 1.45963510 |
44 | MP0002896_abnormal_bone_mineralization | 1.44854645 |
45 | MP0005501_abnormal_skin_physiology | 1.44841970 |
46 | MP0009053_abnormal_anal_canal | 1.39472068 |
47 | MP0002148_abnormal_hypersensitivity_rea | 1.39400462 |
48 | MP0001299_abnormal_eye_distance/ | 1.38998237 |
49 | MP0008260_abnormal_autophagy | 1.35805065 |
50 | MP0009785_altered_susceptibility_to | 1.33172601 |
51 | MP0010368_abnormal_lymphatic_system | 1.31150911 |
52 | MP0000537_abnormal_urethra_morphology | 1.30640675 |
53 | MP0009780_abnormal_chondrocyte_physiolo | 1.30284812 |
54 | MP0005360_urolithiasis | 1.29399734 |
55 | MP0001216_abnormal_epidermal_layer | 1.29024344 |
56 | MP0003950_abnormal_plasma_membrane | 1.28289904 |
57 | MP0001853_heart_inflammation | 1.27806017 |
58 | MP0005451_abnormal_body_composition | 1.27378567 |
59 | MP0000163_abnormal_cartilage_morphology | 1.25990457 |
60 | MP0003300_gastrointestinal_ulcer | 1.25228950 |
61 | MP0002419_abnormal_innate_immunity | 1.23921140 |
62 | MP0005390_skeleton_phenotype | 1.23892558 |
63 | MP0003436_decreased_susceptibility_to | 1.23276024 |
64 | MP0010771_integument_phenotype | 1.22701402 |
65 | MP0008004_abnormal_stomach_pH | 1.20889112 |
66 | MP0001533_abnormal_skeleton_physiology | 1.20624325 |
67 | MP0003329_amyloid_beta_deposits | 1.20533460 |
68 | MP0004858_abnormal_nervous_system | 1.20140711 |
69 | MP0000751_myopathy | 1.19919628 |
70 | MP0002295_abnormal_pulmonary_circulatio | 1.18457395 |
71 | MP0004947_skin_inflammation | 1.17145416 |
72 | MP0003942_abnormal_urinary_system | 1.16350009 |
73 | MP0003448_altered_tumor_morphology | 1.15978739 |
74 | MP0000749_muscle_degeneration | 1.13880517 |
75 | MP0003045_fibrosis | 1.13787882 |
76 | MP0010155_abnormal_intestine_physiology | 1.13744178 |
77 | MP0001849_ear_inflammation | 1.12548538 |
78 | MP0000604_amyloidosis | 1.11637738 |
79 | MP0005464_abnormal_platelet_physiology | 1.11322720 |
80 | MP0003755_abnormal_palate_morphology | 1.11052469 |
81 | MP0001663_abnormal_digestive_system | 1.10890051 |
82 | MP0005025_abnormal_response_to | 1.09393805 |
83 | MP0003303_peritoneal_inflammation | 1.08818399 |
84 | MP0005164_abnormal_response_to | 1.06574783 |
85 | MP0002332_abnormal_exercise_endurance | 1.05113654 |
86 | MP0003724_increased_susceptibility_to | 1.03606398 |
87 | MP0000343_altered_response_to | 1.03588760 |
88 | MP0002933_joint_inflammation | 1.01353075 |
89 | MP0000566_synostosis | 1.01100985 |
90 | MP0002998_abnormal_bone_remodeling | 0.99091136 |
91 | MP0000013_abnormal_adipose_tissue | 0.98359212 |
92 | MP0003795_abnormal_bone_structure | 0.96756962 |
93 | MP0001348_abnormal_lacrimal_gland | 0.96545820 |
94 | MP0002168_other_aberrant_phenotype | 0.95325392 |
95 | MP0000685_abnormal_immune_system | 0.95255358 |
96 | MP0000627_abnormal_mammary_gland | 0.94496195 |
97 | MP0000049_abnormal_middle_ear | 0.94425473 |
98 | MP0000377_abnormal_hair_follicle | 0.92353683 |
99 | MP0000678_abnormal_parathyroid_gland | 0.92321945 |
100 | MP0010678_abnormal_skin_adnexa | 0.92165312 |
101 | MP0002115_abnormal_skeleton_extremities | 0.92159154 |
102 | MP0000490_abnormal_crypts_of | 0.91767842 |
103 | MP0005197_abnormal_uvea_morphology | 0.91031942 |
104 | MP0004883_abnormal_blood_vessel | 0.89761122 |
105 | MP0003385_abnormal_body_wall | 0.89634966 |
106 | MP0009333_abnormal_splenocyte_physiolog | 0.89225262 |
107 | MP0002113_abnormal_skeleton_development | 0.88941565 |
108 | MP0005083_abnormal_biliary_tract | 0.88509686 |
109 | MP0001835_abnormal_antigen_presentation | 0.87586027 |
110 | MP0002177_abnormal_outer_ear | 0.87137427 |
111 | MP0001845_abnormal_inflammatory_respons | 0.86201292 |
112 | MP0001879_abnormal_lymphatic_vessel | 0.84966489 |
113 | MP0000767_abnormal_smooth_muscle | 0.84345029 |
114 | MP0002132_abnormal_respiratory_system | 0.83217255 |
115 | MP0002098_abnormal_vibrissa_morphology | 0.83037648 |
116 | MP0005193_abnormal_anterior_eye | 0.82862575 |
117 | MP0005381_digestive/alimentary_phenotyp | 0.81865655 |
118 | MP0005387_immune_system_phenotype | 0.81724555 |
119 | MP0001790_abnormal_immune_system | 0.81724555 |
120 | MP0002452_abnormal_antigen_presenting | 0.81526335 |
121 | MP0008469_abnormal_protein_level | 0.81416006 |
122 | MP0002234_abnormal_pharynx_morphology | 0.80933115 |
123 | MP0002405_respiratory_system_inflammati | 0.80033968 |
124 | MP0005000_abnormal_immune_tolerance | 0.79776729 |
125 | MP0009764_decreased_sensitivity_to | 0.79447004 |
126 | MP0004185_abnormal_adipocyte_glucose | 0.78480083 |
127 | MP0000428_abnormal_craniofacial_morphol | 0.78467481 |
128 | MP0000681_abnormal_thyroid_gland | 0.76580387 |
129 | MP0002108_abnormal_muscle_morphology | 0.75912440 |
130 | MP0005367_renal/urinary_system_phenotyp | 0.75796315 |
131 | MP0000516_abnormal_urinary_system | 0.75796315 |
132 | MP0000427_abnormal_hair_cycle | 0.75683489 |
133 | MP0001191_abnormal_skin_condition | 0.74486286 |
134 | MP0005595_abnormal_vascular_smooth | 0.74447223 |
135 | MP0005330_cardiomyopathy | 0.73007654 |
136 | MP0000249_abnormal_blood_vessel | 0.72190388 |
137 | MP0001614_abnormal_blood_vessel | 0.70524017 |
138 | MP0009931_abnormal_skin_appearance | 0.70514245 |
139 | MP0000647_abnormal_sebaceous_gland | 0.69770826 |
140 | MP0004808_abnormal_hematopoietic_stem | 0.68630148 |
141 | MP0000534_abnormal_ureter_morphology | 0.67353769 |
142 | MP0001340_abnormal_eyelid_morphology | 0.66878111 |
143 | MP0010307_abnormal_tumor_latency | 0.65453384 |
144 | MP0000467_abnormal_esophagus_morphology | 0.65018622 |
145 | MP0001346_abnormal_lacrimal_gland | 0.64698868 |
146 | MP0000383_abnormal_hair_follicle | 0.64642297 |
147 | MP0003115_abnormal_respiratory_system | 0.64462364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 6.51118516 |
2 | Premature rupture of membranes (HP:0001788) | 6.47516571 |
3 | Atrophic scars (HP:0001075) | 5.12016167 |
4 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.16984316 |
5 | Vertebral compression fractures (HP:0002953) | 3.92949813 |
6 | Peritonitis (HP:0002586) | 3.89942700 |
7 | Shallow orbits (HP:0000586) | 3.77435698 |
8 | Fragile skin (HP:0001030) | 3.64404935 |
9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.56987799 |
10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.56987799 |
11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.56987799 |
12 | Aortic dissection (HP:0002647) | 3.49992940 |
13 | Increased connective tissue (HP:0009025) | 3.46025360 |
14 | Neonatal short-limb short stature (HP:0008921) | 3.45068199 |
15 | Soft skin (HP:0000977) | 3.44839752 |
16 | Ankle contracture (HP:0006466) | 3.44098936 |
17 | Short nail (HP:0001799) | 3.36007361 |
18 | Spinal rigidity (HP:0003306) | 3.27523989 |
19 | Aortic aneurysm (HP:0004942) | 3.25884039 |
20 | Wormian bones (HP:0002645) | 3.21276815 |
21 | Cervical subluxation (HP:0003308) | 3.20914320 |
22 | Increased density of long bones (HP:0006392) | 3.19735708 |
23 | Dilatation of the ascending aorta (HP:0005111) | 3.19663484 |
24 | Fragile nails (HP:0001808) | 3.18281105 |
25 | Abnormality of dentin (HP:0010299) | 3.12566562 |
26 | Osteolytic defects of the hand bones (HP:0009699) | 3.09772828 |
27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.09772828 |
28 | Amyloidosis (HP:0011034) | 3.08588744 |
29 | Glucose intolerance (HP:0000833) | 3.06227462 |
30 | Abnormal hemoglobin (HP:0011902) | 3.01494580 |
31 | Cerebral aneurysm (HP:0004944) | 2.94454972 |
32 | Milia (HP:0001056) | 2.91207238 |
33 | Axonal loss (HP:0003447) | 2.82975689 |
34 | Onycholysis (HP:0001806) | 2.79022800 |
35 | Trismus (HP:0000211) | 2.75169357 |
36 | Cardiovascular calcification (HP:0011915) | 2.74356391 |
37 | Nuclear cataract (HP:0100018) | 2.68628190 |
38 | Blue sclerae (HP:0000592) | 2.67508925 |
39 | Interstitial pulmonary disease (HP:0006530) | 2.63930022 |
40 | Abnormality of the 2nd finger (HP:0004100) | 2.63784468 |
41 | Right ventricular cardiomyopathy (HP:0011663) | 2.60989698 |
42 | Vascular calcification (HP:0004934) | 2.60454776 |
43 | Vascular tortuosity (HP:0004948) | 2.60210254 |
44 | Biconcave vertebral bodies (HP:0004586) | 2.58579146 |
45 | Sparse lateral eyebrow (HP:0005338) | 2.56717907 |
46 | Generalized amyotrophy (HP:0003700) | 2.54154044 |
47 | Distal lower limb muscle weakness (HP:0009053) | 2.52801341 |
48 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.43788082 |
49 | Dysostosis multiplex (HP:0000943) | 2.41968926 |
50 | Rough bone trabeculation (HP:0100670) | 2.41493000 |
51 | Type 1 muscle fiber predominance (HP:0003803) | 2.39874809 |
52 | Spondylolisthesis (HP:0003302) | 2.39168798 |
53 | Follicular hyperkeratosis (HP:0007502) | 2.38928311 |
54 | Genu recurvatum (HP:0002816) | 2.38665370 |
55 | Distal lower limb amyotrophy (HP:0008944) | 2.35799900 |
56 | Coronal craniosynostosis (HP:0004440) | 2.34138585 |
57 | Spinal cord compression (HP:0002176) | 2.31861442 |
58 | Abnormality of macrophages (HP:0004311) | 2.28527364 |
59 | Elbow flexion contracture (HP:0002987) | 2.27451637 |
60 | Vacuolated lymphocytes (HP:0001922) | 2.22285749 |
61 | Wrist flexion contracture (HP:0001239) | 2.21297497 |
62 | Arterial tortuosity (HP:0005116) | 2.20063556 |
63 | Natal tooth (HP:0000695) | 2.16639271 |
64 | Abnormality of the nasal mucosa (HP:0000433) | 2.15827060 |
65 | Achilles tendon contracture (HP:0001771) | 2.15751027 |
66 | Abnormality of the acetabulum (HP:0003170) | 2.15048003 |
67 | Abnormal glucose tolerance (HP:0001952) | 2.14463529 |
68 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.12992842 |
69 | Mitral valve prolapse (HP:0001634) | 2.12962557 |
70 | Pterygium (HP:0001059) | 2.11592178 |
71 | Down-sloping shoulders (HP:0200021) | 2.09672713 |
72 | Mitral regurgitation (HP:0001653) | 2.08579067 |
73 | Broad metatarsal (HP:0001783) | 2.08127376 |
74 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.07764481 |
75 | Vertebral hypoplasia (HP:0008417) | 2.07764481 |
76 | Coxa vara (HP:0002812) | 2.07358105 |
77 | Syringomyelia (HP:0003396) | 2.06805065 |
78 | Spinal cord lesions (HP:0100561) | 2.06805065 |
79 | Woolly hair (HP:0002224) | 2.06423571 |
80 | Joint stiffness (HP:0001387) | 2.06183039 |
81 | Scapular winging (HP:0003691) | 2.04681201 |
82 | Bladder diverticulum (HP:0000015) | 2.03065897 |
83 | Hyperextensible skin (HP:0000974) | 2.02764081 |
84 | Abnormal delivery (HP:0001787) | 2.02412553 |
85 | Congenital, generalized hypertrichosis (HP:0004540) | 2.01870649 |
86 | Thin bony cortex (HP:0002753) | 2.00889376 |
87 | Alopecia of scalp (HP:0002293) | 2.00485966 |
88 | Deviation of the hallux (HP:0010051) | 1.99941698 |
89 | Beaking of vertebral bodies (HP:0004568) | 1.98851865 |
90 | Nasal polyposis (HP:0100582) | 1.98712239 |
91 | Chin dimple (HP:0010751) | 1.98366580 |
92 | Buphthalmos (HP:0000557) | 1.97658500 |
93 | Nail dystrophy (HP:0008404) | 1.96920928 |
94 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96842996 |
95 | Neurofibrillary tangles (HP:0002185) | 1.96424302 |
96 | Ulnar bowing (HP:0003031) | 1.95993336 |
97 | Plantar hyperkeratosis (HP:0007556) | 1.95898161 |
98 | Upper limb muscle weakness (HP:0003484) | 1.95332749 |
99 | Difficulty climbing stairs (HP:0003551) | 1.95188935 |
100 | Reticulocytopenia (HP:0001896) | 1.93956276 |
101 | Hand muscle atrophy (HP:0009130) | 1.93264746 |
102 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.91541821 |
103 | Hallux valgus (HP:0001822) | 1.90655890 |
104 | Abnormality of the calcaneus (HP:0008364) | 1.90653685 |
105 | Delayed cranial suture closure (HP:0000270) | 1.90500032 |
106 | Overgrowth (HP:0001548) | 1.89653852 |
107 | Acanthosis nigricans (HP:0000956) | 1.88262176 |
108 | Fused cervical vertebrae (HP:0002949) | 1.87927569 |
109 | Limb-girdle muscle atrophy (HP:0003797) | 1.87919531 |
110 | Hepatosplenomegaly (HP:0001433) | 1.86452597 |
111 | Abnormal trabecular bone morphology (HP:0100671) | 1.86153883 |
112 | Abnormality of the Achilles tendon (HP:0005109) | 1.85035813 |
113 | Thick nail (HP:0001805) | 1.84934504 |
114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83537709 |
115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83537709 |
116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83537709 |
117 | Camptodactyly of toe (HP:0001836) | 1.81922266 |
118 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80888222 |
119 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80888222 |
120 | Aplasia involving bones of the extremities (HP:0009825) | 1.80888222 |
121 | Mucopolysacchariduria (HP:0008155) | 1.79967616 |
122 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79967616 |
123 | Entropion (HP:0000621) | 1.79620800 |
124 | Tibial bowing (HP:0002982) | 1.78971846 |
125 | Radial bowing (HP:0002986) | 1.78573422 |
126 | Hypertriglyceridemia (HP:0002155) | 1.76436776 |
127 | Distal upper limb amyotrophy (HP:0007149) | 1.76230363 |
128 | Upper limb amyotrophy (HP:0009129) | 1.76230363 |
129 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76222649 |
130 | Lower limb amyotrophy (HP:0007210) | 1.73844632 |
131 | Flat acetabular roof (HP:0003180) | 1.73761599 |
132 | Mitral stenosis (HP:0001718) | 1.73626719 |
133 | Palmoplantar hyperkeratosis (HP:0000972) | 1.72992438 |
134 | Congenital glaucoma (HP:0001087) | 1.72604260 |
135 | Eczematoid dermatitis (HP:0000976) | 1.71765408 |
136 | Abnormality of carpal bone ossification (HP:0006257) | 1.71531820 |
137 | Broad face (HP:0000283) | 1.71390646 |
138 | Bronchomalacia (HP:0002780) | 1.70740127 |
139 | Myocardial infarction (HP:0001658) | 1.69763047 |
140 | Broad hallux (HP:0010055) | 1.68644739 |
141 | Purpura (HP:0000979) | 1.68384730 |
142 | Bradycardia (HP:0001662) | 1.67507041 |
143 | Loss of speech (HP:0002371) | 1.67219562 |
144 | Steatorrhea (HP:0002570) | 1.63344787 |
145 | Prolonged neonatal jaundice (HP:0006579) | 1.63102980 |
146 | Abnormal blistering of the skin (HP:0008066) | 1.62823610 |
147 | Abnormality of complement system (HP:0005339) | 1.61737972 |
148 | Polygenic inheritance (HP:0010982) | 1.60967745 |
149 | Insulin resistance (HP:0000855) | 1.60930337 |
150 | Multiple lipomas (HP:0001012) | 1.60237110 |
151 | Sparse eyelashes (HP:0000653) | 1.59125801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 4.47283781 |
2 | LATS2 | 3.35832748 |
3 | TESK1 | 3.28942529 |
4 | EPHA2 | 3.13347632 |
5 | MOS | 3.11428397 |
6 | LIMK1 | 2.88894963 |
7 | TTN | 2.78814147 |
8 | IRAK3 | 2.73293592 |
9 | PIM2 | 2.59012893 |
10 | LMTK2 | 2.58746029 |
11 | MST4 | 2.58470171 |
12 | TRIB3 | 2.57123404 |
13 | MKNK2 | 2.50050754 |
14 | EPHB2 | 2.44370426 |
15 | LRRK2 | 2.44068391 |
16 | TESK2 | 2.43584761 |
17 | PAK2 | 2.32206598 |
18 | TAOK1 | 2.29207313 |
19 | ERN1 | 2.14006714 |
20 | DDR2 | 2.12817561 |
21 | TRPM7 | 2.07578045 |
22 | MST1R | 1.95231691 |
23 | RPS6KA4 | 1.87669745 |
24 | MAP3K12 | 1.86936942 |
25 | PKN2 | 1.81391382 |
26 | PAK4 | 1.75731154 |
27 | ARAF | 1.73320482 |
28 | LATS1 | 1.65462177 |
29 | BMX | 1.59623651 |
30 | PTK2 | 1.51934949 |
31 | PAK6 | 1.50386470 |
32 | ILK | 1.48426741 |
33 | MET | 1.46622168 |
34 | PDGFRA | 1.44516003 |
35 | PTK6 | 1.40037849 |
36 | FER | 1.37736482 |
37 | STK10 | 1.34772806 |
38 | NEK9 | 1.28785741 |
39 | FRK | 1.19815934 |
40 | ERBB3 | 1.18544875 |
41 | PRPF4B | 1.17476158 |
42 | ROCK2 | 1.16984888 |
43 | ROCK1 | 1.16352451 |
44 | PBK | 1.10422913 |
45 | MAP3K3 | 1.08426237 |
46 | MAP2K1 | 1.05332626 |
47 | RPS6KB2 | 1.04723242 |
48 | STK3 | 1.02726036 |
49 | WNK1 | 1.01262207 |
50 | PTK2B | 0.95932241 |
51 | MKNK1 | 0.95024165 |
52 | ZAP70 | 0.94264715 |
53 | PAK1 | 0.92005662 |
54 | DMPK | 0.89877517 |
55 | PRKG2 | 0.87349820 |
56 | PIK3CG | 0.85558020 |
57 | MAP3K1 | 0.84227901 |
58 | GRK7 | 0.83307152 |
59 | SIK1 | 0.83306061 |
60 | MAP2K2 | 0.83057412 |
61 | SCYL2 | 0.78576237 |
62 | PAK3 | 0.77334272 |
63 | CDK6 | 0.76311977 |
64 | ABL2 | 0.74849044 |
65 | DYRK1B | 0.74804132 |
66 | VRK2 | 0.73814616 |
67 | TLK1 | 0.73760087 |
68 | MAP3K2 | 0.72558136 |
69 | RIPK1 | 0.71905447 |
70 | MAP3K5 | 0.69636460 |
71 | PIK3CA | 0.69587457 |
72 | MAPKAPK2 | 0.69281103 |
73 | MAP3K8 | 0.68344961 |
74 | SIK3 | 0.67957362 |
75 | TYK2 | 0.65725646 |
76 | STK38L | 0.65207455 |
77 | FGFR1 | 0.65050104 |
78 | STK38 | 0.64990837 |
79 | EEF2K | 0.63881592 |
80 | PRKD1 | 0.60259549 |
81 | NTRK1 | 0.59228213 |
82 | BLK | 0.58844798 |
83 | MAPKAPK3 | 0.58343741 |
84 | SMG1 | 0.58151909 |
85 | DAPK1 | 0.57929721 |
86 | DAPK3 | 0.55950775 |
87 | CSK | 0.55571511 |
88 | TGFBR1 | 0.55425843 |
89 | EPHB1 | 0.55159124 |
90 | MAP3K6 | 0.54207627 |
91 | PRKD2 | 0.54096703 |
92 | CDC42BPA | 0.53888185 |
93 | CAMK2D | 0.53000792 |
94 | AURKB | 0.50468064 |
95 | TBK1 | 0.47050996 |
96 | INSR | 0.46848406 |
97 | ICK | 0.46135966 |
98 | TGFBR2 | 0.44616712 |
99 | PDGFRB | 0.43964314 |
100 | KDR | 0.43257632 |
101 | MAP3K11 | 0.42884031 |
102 | TAOK2 | 0.41481643 |
103 | CDK14 | 0.41466846 |
104 | GSK3A | 0.40694305 |
105 | MAPKAPK5 | 0.39602828 |
106 | MAP3K14 | 0.39542727 |
107 | ADRBK1 | 0.38966275 |
108 | BRAF | 0.38193292 |
109 | IRAK4 | 0.38040134 |
110 | JAK3 | 0.36663964 |
111 | MAP2K3 | 0.36506962 |
112 | MYLK | 0.36328080 |
113 | PRKCI | 0.36236290 |
114 | CDK8 | 0.36148623 |
115 | MARK3 | 0.35900668 |
116 | SRC | 0.31887095 |
117 | IKBKB | 0.30905892 |
118 | CDK15 | 0.30898526 |
119 | EGFR | 0.29755279 |
120 | PDPK1 | 0.29155737 |
121 | ERBB4 | 0.28445126 |
122 | STK24 | 0.28063831 |
123 | CDK18 | 0.27723251 |
124 | MUSK | 0.27059798 |
125 | CDK11A | 0.26470837 |
126 | PHKG2 | 0.26119443 |
127 | PHKG1 | 0.26119443 |
128 | CAMK2G | 0.25833647 |
129 | GRK5 | 0.25595511 |
130 | RET | 0.25487843 |
131 | ABL1 | 0.25032932 |
132 | FLT3 | 0.24912216 |
133 | BUB1 | 0.23241221 |
134 | ERBB2 | 0.22773903 |
135 | HIPK2 | 0.21962483 |
136 | BMPR2 | 0.21838346 |
137 | JAK1 | 0.21823816 |
138 | MELK | 0.21512115 |
139 | PRKCD | 0.21422048 |
140 | NME1 | 0.20379147 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.49129943 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.93849149 |
3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.92779181 |
4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.79336532 |
5 | Bladder cancer_Homo sapiens_hsa05219 | 2.76089414 |
6 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.74163433 |
7 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.47914464 |
8 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.44802751 |
9 | Focal adhesion_Homo sapiens_hsa04510 | 2.31506195 |
10 | Adherens junction_Homo sapiens_hsa04520 | 2.14205360 |
11 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.05128250 |
12 | Galactose metabolism_Homo sapiens_hsa00052 | 1.99063751 |
13 | Malaria_Homo sapiens_hsa05144 | 1.95766032 |
14 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.87420788 |
15 | Amoebiasis_Homo sapiens_hsa05146 | 1.86690945 |
16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.86229419 |
17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.80746581 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80556091 |
19 | Shigellosis_Homo sapiens_hsa05131 | 1.78563840 |
20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.74406263 |
21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.67119479 |
22 | Melanoma_Homo sapiens_hsa05218 | 1.62793217 |
23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.59765832 |
24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58492038 |
25 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.55676810 |
26 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.53671180 |
27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53570783 |
28 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.51559937 |
29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50166595 |
30 | Salmonella infection_Homo sapiens_hsa05132 | 1.47339780 |
31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.45836288 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41720762 |
33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.36323781 |
34 | Tight junction_Homo sapiens_hsa04530 | 1.32915405 |
35 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.27396977 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24184586 |
37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.24058617 |
38 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.21385302 |
39 | Apoptosis_Homo sapiens_hsa04210 | 1.20331977 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19628448 |
41 | Pertussis_Homo sapiens_hsa05133 | 1.18913574 |
42 | Phagosome_Homo sapiens_hsa04145 | 1.18002785 |
43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15901419 |
44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13075123 |
45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12718164 |
46 | Platelet activation_Homo sapiens_hsa04611 | 1.09874851 |
47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07430963 |
48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04239806 |
49 | Glioma_Homo sapiens_hsa05214 | 0.99284964 |
50 | Mineral absorption_Homo sapiens_hsa04978 | 0.98857033 |
51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97311317 |
52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95751605 |
53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92706934 |
54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89481039 |
55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89416521 |
56 | Pathways in cancer_Homo sapiens_hsa05200 | 0.88775580 |
57 | Prion diseases_Homo sapiens_hsa05020 | 0.88644824 |
58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88095244 |
59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87593341 |
60 | Influenza A_Homo sapiens_hsa05164 | 0.87541460 |
61 | Legionellosis_Homo sapiens_hsa05134 | 0.86852503 |
62 | Tuberculosis_Homo sapiens_hsa05152 | 0.86024134 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85573487 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85493339 |
65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84858907 |
66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84414019 |
67 | Hepatitis C_Homo sapiens_hsa05160 | 0.83562171 |
68 | Hepatitis B_Homo sapiens_hsa05161 | 0.80360522 |
69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79833782 |
70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79424386 |
71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78737918 |
72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78329144 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78092052 |
74 | Allograft rejection_Homo sapiens_hsa05330 | 0.78035371 |
75 | Protein export_Homo sapiens_hsa03060 | 0.77850802 |
76 | Axon guidance_Homo sapiens_hsa04360 | 0.76066636 |
77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75617765 |
78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74397535 |
79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73515821 |
80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73431768 |
81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72886290 |
82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72278040 |
83 | Endocytosis_Homo sapiens_hsa04144 | 0.71685778 |
84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71492368 |
85 | Proteasome_Homo sapiens_hsa03050 | 0.71327552 |
86 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.68333824 |
87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67992451 |
88 | Prostate cancer_Homo sapiens_hsa05215 | 0.67214779 |
89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66918927 |
90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66482337 |
91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65200928 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64973697 |
93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64176788 |
94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63573069 |
95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62378136 |
96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61437194 |
97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59688103 |
98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57877261 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56975106 |
100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56743908 |
101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56147490 |
102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55287697 |
103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55085028 |
104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54922089 |
105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54503201 |
106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53395106 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.51678444 |
108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50735496 |
109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50526867 |
110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50466023 |
111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50399979 |
112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50150394 |
113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49083447 |
114 | Measles_Homo sapiens_hsa05162 | 0.48743377 |
115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47898148 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47711720 |
117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44052809 |
118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44030304 |
119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43770448 |
120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43189407 |
121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42463676 |
122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41438216 |
123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39651958 |
124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39594693 |
125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39357295 |
126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38079018 |
127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37499222 |
128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37218987 |
129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36789674 |
130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36296430 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35368457 |
132 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34389331 |
133 | Gap junction_Homo sapiens_hsa04540 | 0.33059890 |
134 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31730345 |
135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30527220 |